A1.07 Liquid Biopsy Unit

A multifunctional unit dedicated to liquid biopsy R&D developments and services will be integrated into P5. Both research-use technologies (RUO) and certified technologies will be defined in this dedicated unit to offer state-of-the-art equipment to both the hospital and cancer researchers. Translation research will thus have a faster clinical uptake also in direct collaboration with pharma.

Date Start

Jan. 2, 2023

Date End

Dec. 31, 2025